Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
57.7M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$41.4M
-
Put/Call ratio
-
0.76
-
Number of buys
-
82
-
Number of sells
-
-62
-
Price
-
$28.08
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2022
187 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2022.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.7M shares
of 58.6M outstanding shares and own 98.37% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.46M shares), VANGUARD GROUP INC (5.34M shares), BlackRock Inc. (4.77M shares), Bellevue Group AG (4.06M shares), STATE STREET CORP (3.18M shares), Rock Springs Capital Management LP (3M shares), ARMISTICE CAPITAL, LLC (2.75M shares), FARALLON CAPITAL MANAGEMENT LLC (2.03M shares), Erste Asset Management GmbH (1.69M shares), and DIMENSIONAL FUND ADVISORS LP (1.65M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.